C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab

Eduard Roussel; Lisa Kinget; Annelies Verbiest; Philip R. Debruyne; Marcella Baldewijns; Hendrik Van Poppel; Maarten Albersen; Benoit Beuselinck

doi:10.1016/j.urolonc.2020.12.020

C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab

Eduard Roussel, Lisa Kinget, Annelies Verbiest, Philip R. Debruyne, Marcella Baldewijns, Hendrik Van Poppel, Maarten Albersen, Benoit Beuselinck

School of Nursing and Midwifery

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	239.e17-239.e25
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	39
Issue number	4
DOIs	https://doi.org/10.1016/j.urolonc.2020.12.020
Publication status	Published - 1 Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.urolonc.2020.12.020

https://linkinghub.elsevier.com/retrieve/pii/S1078143920306499

Cite this

Roussel, E., Kinget, L., Verbiest, A., Debruyne, P. R., Baldewijns, M., Van Poppel, H., Albersen, M., & Beuselinck, B. (2021). C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab. Urologic Oncology: Seminars and Original Investigations, 39(4), 239.e17-239.e25. https://doi.org/10.1016/j.urolonc.2020.12.020

@article{e5abb87f0caa4af0aee9f304b7943d75,

title = "C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab",

author = "Eduard Roussel and Lisa Kinget and Annelies Verbiest and Debruyne, {Philip R.} and Marcella Baldewijns and {Van Poppel}, Hendrik and Maarten Albersen and Benoit Beuselinck",

year = "2021",

month = apr,

day = "1",

doi = "10.1016/j.urolonc.2020.12.020",

language = "English",

volume = "39",

pages = "239.e17--239.e25",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "4",

}

Roussel, E, Kinget, L, Verbiest, A, Debruyne, PR, Baldewijns, M, Van Poppel, H, Albersen, M & Beuselinck, B 2021, 'C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab', Urologic Oncology: Seminars and Original Investigations, vol. 39, no. 4, pp. 239.e17-239.e25. https://doi.org/10.1016/j.urolonc.2020.12.020

C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab. / Roussel, Eduard; Kinget, Lisa; Verbiest, Annelies et al.
In: Urologic Oncology: Seminars and Original Investigations, Vol. 39, No. 4, 01.04.2021, p. 239.e17-239.e25.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab

AU - Roussel, Eduard

AU - Kinget, Lisa

AU - Verbiest, Annelies

AU - Debruyne, Philip R.

AU - Baldewijns, Marcella

AU - Van Poppel, Hendrik

AU - Albersen, Maarten

AU - Beuselinck, Benoit

PY - 2021/4/1

Y1 - 2021/4/1

U2 - 10.1016/j.urolonc.2020.12.020

DO - 10.1016/j.urolonc.2020.12.020

M3 - Article

SN - 1078-1439

VL - 39

SP - 239.e17-239.e25

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 4

ER -